CASE REPORTS
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Quadriceps Hematoma. A prospective clinical study.

A prospective study of 60 patients with quadriceps hematomas was carried out in an attempt to gain a better understanding of the pathogenesis, characteristics, and morbidity of this condition, including those patients in whom ossification occurs. The patients ranged in age from 15 to 25 years; thirty-six were injured playing rugby football. The knee was the most common site. In ten patients heterotopic ossification developed. The three phases of management are rest, knee mobilization, and restoration of quadriceps function. The average hospitalization period in the 28 inpatients was eight days. The average time away from work in the 40 employed patients was four weeks. Both hospitalization and disability times were greater in those patients in whom ossification developed. 99m-Technetium-diphosphonate scanning, carried out in ten patients, was useful for determining the site and size of the bleed. The study has elucidated the epidemiology and morbidity and has been successfully used in an education program. Investigations to determine the localization of the hematoma and to predict ossification were unsuccessful.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app